Drug
Gonadotropin Releasing Hormone Antagonist clinical trials
- studies test it
- 22
- open now
- 1
- in phase 3
- 4
- first study started
- 2002
Keep track of what changes. Save the Gonadotropin Releasing Hormone Antagonist studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
22 studies that test it; most in 2017 (6)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 6 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 4
- Phase 4
- 7
- No phase
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 21
University of Colorado, Denver (2) · Turku University Hospital (2) · Cairo University (2) · Bezmialem Vakif University (1) · Organon and Co (1) · Lebanese University (1) · IVI Madrid (1) · Lund University (1)
Often tested with
Tested in the same studies.
Chorionic Gonadotropin (3) · Gonadotropin-releasing Hormone Analog (3) · Gonadotropins (3) · Progesterone (2) · Medroxyprogesterone Acetate (1) · Medroxyprogesterone (1) · Dydrogesterone (1) · Corifollitropin alfa (1)
Studies
Open first, then newest update. How each study uses Gonadotropin Releasing Hormone Antagonist is read from its arms, and is right about nine times in ten.
Testing it · 22
- Bioenergetic Effects of Aging and Menopause (BEAM)RecruitingPhase 4University of Colorado, DenverNCT04043520Written as GnRH antagonist
- Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study)Active, not recruitingPhase 4University of Colorado, DenverNCT05057546Written as GnRH antagonist
- Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation CyclesCompletedNot applicableBezmialem Vakif UniversityNCT05767086Written as Gonadotropin releasing hormone antagonist (Cetrotide)
- Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)CompletedPhase 3Organon and CoNCT00696878Written as GnRH antagonist
- Mechanisms of Hypertension in Women With Polycystic Ovary SyndromeTerminatedEarly Phase 1Yale UniversityNCT04327934Written as GnRH antagonist
- Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female InfertilityCompletedPhase 1/2Lebanese UniversityNCT04071574Written as GnRH antagonist
- The Effect of ADT on PSMA Expression in Metastatic Prostate CancerStatus unknownNot applicableTurku University HospitalNCT03876912Written as GnRH antagonist
- DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScoreCompletedNot applicableIVI MadridNCT03291821Written as GnRH antagonist
- Random-start Ovarian Stimulation in Egg-donors (ROSE)TerminatedPhase 4Instituto BernabeuNCT02821819Written as GnRH antagonist
- Testosterone-Dependent Effects on Protein Biomarkers From Healthy MalesCompletedNot applicableLund UniversityNCT03541395Written as GnRH antagonist
- Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist ProtocolStatus unknownNot applicableCairo UniversityNCT03484611Written as GnRH antagonist
- The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI CyclesStatus unknownNot applicableCairo UniversityNCT03457233Written as GNRH antagonist
- The Effect of ADT on PSMA-PET.Status unknownNot applicableTurku University HospitalNCT03313726Written as GnRH antagonist
- GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo TransferCompletedPhase 3Seoul National University HospitalNCT01402336Written as GnRH antagonist (Cetrorelix)
- Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing ChemotherapyWithdrawnPhase 4Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT00507780Written as GnRH antagonist
- Preventive Application of GnRH Antagonist on Early OHSSStatus unknownPhase 4First Affiliated Hospital, Sun Yat-Sen UniversityNCT03188471Written as GnRH antagonist
- Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo QualityStatus unknownPhase 2/3Assiut UniversityNCT03139474Written as Gonadotropin releasing hormone antagonist
- GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation SyndromeCompletedPhase 3Instituto Valenciano de Infertilidad, IVI VALENCIANCT01268761Written as GnRH antagonist (Cetrorelix)
- Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus AntagonistCompletedPhase 4Universitair Ziekenhuis BrusselNCT01888744Written as GnRH antagonist
- Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH MenCompletedNot applicableNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00470990Written as GnRH antagonist (Acyline)
See all 22 studies that test Gonadotropin Releasing Hormone Antagonist →
Given in every arm · 13 — Gonadotropin Releasing Hormone Antagonist is usual care beside what is tested
- GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer PatientsRecruitingPhase 2/3Xiaojun ChenNCT06379113Written as GnRH antagonist
- Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic AdvantageEnrolling by invitationNot applicableLTD "EKODNIPRO", Medical centre Medical Plaza DniproNCT07771283Written as GnRH antagonist
- Evaluation of Neoadjuvant Xaluritamig in Localized Prostate CancerRecruitingPhase 1AmgenNCT06613100Written as GnRH Antagonist
- The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in HumansNot yet recruitingNot applicableUniversity of British ColumbiaNCT07212712Written as GnRH antagonist
- Effect of GH on the Blastocyst Euploid Rate in AMA PatientsRecruitingPhase 3ShangHai Ji Ai Genetics & IVF InstituteNCT05447208Written as GnRH antagonist
- Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate CancerWithdrawnPhase 2OHSU Knight Cancer InstituteNCT06528210Written as Gonadotropin Releasing Hormone Agonists and Antagonists
- GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia PatientsActive, not recruitingPhase 2/3Xiaojun ChenNCT06390904Written as GnRH antagonist
- Effect of GH Supplementation on the Blastocyst Euploid Rate in AMA Patients--A Retrospective Cohort StudyCompletedPhase 3ShangHai Ji Ai Genetics & IVF InstituteNCT05574894Written as GnRH antagonist
- Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI CyclesCompletedPhase 4Cairo UniversityNCT04008966Written as GnRH antagonist
- Letrozole Treatment in Normal and GnRH Deficient WomenStatus unknownPhase 1/2Massachusetts General HospitalNCT00351416Written as NAL-GLU GnRH antagonist
- The Effects of Aging and Estrogen on the PituitaryStatus unknownPhase 2/3Massachusetts General HospitalNCT00386022Written as NAL-GLU GnRH antagonist
- A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive AgeTerminatedPhase 2Merck KGaA, Darmstadt, GermanyNCT01079949Written as GnRH antagonist
- Metabolic Effects of Steroids in Obese MenStatus unknownNot applicableNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00983554Written as GnRH antagonist
As the comparator · 7 — what is tested is compared with Gonadotropin Releasing Hormone Antagonist
- Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian StimulationRecruitingPhase 2Bedaya HospitalNCT06212102Written as GnRH antagonist
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-ANot yet recruitingPhase 3ShangHai Ji Ai Genetics & IVF InstituteNCT05326087Written as GnRH antagonist
- Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF OutcomesNot yet recruitingPhase 4Nesta ClinicNCT06396390Written as GnRH antagonist
- Late-Start Corifollitropin Alfa in Mild Ovarian StimulationCompletedNot applicableAssisting NatureNCT07891793Written as GnRH antagonist
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-ACompletedPhase 3ShangHai Ji Ai Genetics & IVF InstituteNCT04414748Written as GnRH antagonist
- Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian ResponseCompletedPhase 3ShangHai Ji Ai Genetics & IVF InstituteNCT04414761Written as GnRH Antagonist
- Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.CompletedNot applicableFundacion DexeusNCT04108039Written as GnRh antagonist